• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A note on the analysis of titration studies.

作者信息

Chuang-Stein C, Shih W J

机构信息

Research Support Biostatistics Unit, Upjohn Company, Kalamazoo, MI 49001.

出版信息

Stat Med. 1991 Mar;10(3):323-8. doi: 10.1002/sim.4780100304.

DOI:10.1002/sim.4780100304
PMID:2028116
Abstract

We propose a method to incorporate all types of dropouts in the evaluation of an intervention based on binary data from a titration study. The proposed procedure does not require that the dropouts occur randomly, but instead examines each outcome individually. Our procedure has a built-in penalty factor in the estimation process that determines the amount of penalty on efficacy parameters due to efficacy-related dropouts. We also propose a method to estimate the variances associated with the estimates. The results have use in exploration of a potential dose-response relationship or to answer questions pertinent for phase III studies. We use data from a phase III antihypertension study to illustrate the procedure.

摘要

相似文献

1
A note on the analysis of titration studies.
Stat Med. 1991 Mar;10(3):323-8. doi: 10.1002/sim.4780100304.
2
The analysis of titration studies in phase III clinical trials.
Stat Med. 1989 May;8(5):583-91. doi: 10.1002/sim.4780080507.
3
The analysis of a titration study.一项滴定研究的分析。
Stat Med. 1987 Jul-Aug;6(5):583-90. doi: 10.1002/sim.4780060507.
4
A simulation study comparing designs for dose ranging.
Stat Med. 1991 Mar;10(3):303-21. doi: 10.1002/sim.4780100303.
5
Defined daily dose (DDD) and its potential use in clinical trials of resistant hypertension.限定日剂量(DDD)及其在顽固性高血压临床试验中的潜在应用。
Int J Cardiol. 2016 Jan 1;202:515-6. doi: 10.1016/j.ijcard.2015.09.096. Epub 2015 Sep 28.
6
["High dosage monotherapy"].
Krankenpfl J. 2005;43(1-3):63.
7
Comparison of angiotensin II receptor blockers: impact of missed doses of candesartan cilexetil and losartan in systemic hypertension.血管紧张素 II 受体阻滞剂的比较:坎地沙坦酯和氯沙坦漏服剂量对系统性高血压的影响。
Am J Cardiol. 1999 Nov 18;84(10A):28S-34S. doi: 10.1016/s0002-9149(99)00731-6.
8
A new partition testing strategy for multiple endpoints.一种新的针对多个终点的分区测试策略。
Stat Med. 2012 Sep 10;31(20):2151-68. doi: 10.1002/sim.5366. Epub 2012 Apr 25.
9
[Value of combination therapy in treatment of hypertension].[联合治疗在高血压治疗中的价值]
Krankenpfl J. 2005;43(7-10):255.
10
Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis.固定剂量复方抗高血压药物的依从性、安全性和有效性:一项荟萃分析。
Hypertension. 2010 Feb;55(2):399-407. doi: 10.1161/HYPERTENSIONAHA.109.139816. Epub 2009 Dec 21.